Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 16, 2009Biomedical Chromatography

Systematic LC‐MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought‐out chromatography

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMohammed JemalHaramaya UniversityZOZheng OuyangResearch Institute of Precision Instruments (Russia)YXYuanqing XiaBeijing Institute of Technology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jemal et al. (2009) studied this question.

synapsesocial.com/papers/6a102fa058ed9fc001fcaecbhttps://doi.org/10.1002/bmc.1373
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects2009 · 216 citations
  2. 2A review of chromatographic methods for the assessment of phospholipids in biological samples2005 · 249 citations
  3. 3Study on the formation of an amoxicillin adduct with methanol using electrospray ion trap tandem mass spectrometry2007 · 40 citations